INSY
Insys Therapeutics, Inc.
INSY
INSY
Delisted
INSY was delisted on the 18th of June, 2019.
116 hedge funds and large institutions have $175M invested in Insys Therapeutics, Inc. in 2017 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 37 increasing their positions, 24 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
46% less call options, than puts
Call options by funds: $2.36M | Put options by funds: $4.4M
Holders
116
Holding in Top 10
–
Calls
$2.36M
Puts
$4.4M
Top Buyers
| 1 | +$3.55M | |
| 2 | +$2.35M | |
| 3 | +$1.55M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$998K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$951K |
Top Sellers
| 1 | -$3.41M | |
| 2 | -$2.31M | |
| 3 | -$1.11M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$980K |
| 5 |
GAM
Gotham Asset Management
New York
|
-$892K |